Clinical Trials Directory

Trials / Terminated

TerminatedNCT01972061

Foot/Hand Neuromodulation for Overactive Bladder (OAB)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Christopher J Chermansky, MD · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if electrical stimulation of the foot is effective in the treatment of overactive bladder conditions.

Detailed description

Foot neuromodulation is designed to treat OAB conditions by electrically stimulating the somatic afferent nerves in the foot using skin surface electrodes. The foot stimulation is non-invasive, can be performed at home, and has no adverse effects. Foot neuromodulation therapy will likely be accepted by more patients and have the potential to make a broader impact on the improvement of OAB conditions.

Conditions

Interventions

TypeNameDescription
DEVICEFoot stimulationFoot stimulation electrically activates the somatic afferent nerves in the foot using FDA-approved, commercially available transcutaneous electrical nerve stimulator (TENS) and skin surface electrodes attached to the foot.

Timeline

Start date
2014-03-01
Primary completion
2018-12-11
Completion
2018-12-11
First posted
2013-10-30
Last updated
2020-02-26
Results posted
2020-02-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01972061. Inclusion in this directory is not an endorsement.

Foot/Hand Neuromodulation for Overactive Bladder (OAB) (NCT01972061) · Clinical Trials Directory